Apotea AB (publ) (STO:APOTEA)
Sweden · Delayed Price · Currency is SEK 76.50
-1.70 (-2.17%)
At close: May 7, 2026
Apotea AB Market Cap
Apotea AB has a market cap or net worth of 8.14 billion as of May 7, 2026. Its market cap has increased by 3.67% in one year.
Market Cap
8.14B
Enterprise Value
8.34B
Revenue
7.39B
Ranking
n/a
PE Ratio
34.45
Stock Price
76.50
Market Cap Chart
Since December 6, 2024, Apotea AB's market cap has decreased from 8.63B to 8.14B, a decrease of -5.70%. That is a compound annual growth rate of -4.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 8.14B | -15.20% |
| Dec 30, 2025 | 9.60B | 9.72% |
| Dec 30, 2024 | 8.75B | 1.35% |
| Dec 6, 2024 | 8.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 152.52B |
| Sectra AB | 51.13B |
| Getinge AB | 51.04B |
| Camurus AB | 33.79B |
| Ambea AB | 11.06B |
| Dynavox Group AB | 9.00B |
| Xvivo Perfusion AB | 8.85B |
| Synsam AB | 7.95B |